<DOC>
	<DOC>NCT02222883</DOC>
	<brief_summary>The aim of this prospective registration and translational research study is to evaluate the praevalence of BRCA regarding germline and somatic mutations.</brief_summary>
	<brief_title>Prevalence of BRCA in Patients With Ovarian Cancer</brief_title>
	<detailed_description>Explorative analysis will be performed.</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Female ovarian cancer patients aged &gt;= 18 years. Women with first diagnosis of epithelial ovarian cancer OR women diagnosed with platinumsensitive recurrent ovarian cancer. Multiple platinum based prior therapies are allowed. Nonepithelial ovarian malignancy. Platinumresistant or refractory disease. Paraffin embedded tumor samples not available.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>